Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer, Ovarian Cancer, Gynecologic Cancers, Ovarian/Peritoneal/Fallopian Cancer
Female
Breast Cancer, Ovarian Cancer, Gynecologic Cancers, Ovarian/Peritoneal/Fallopian Cancer
Trial Information
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Inclusion Criteria:
I. Women who have a high risk of developing breast or ovarian cancer due to a known
germline mutation in the BRCA1/2, PTEN, CDH1, or TP53 cancer susceptibility genes, or due
to strong family history of either breast or ovarian cancer, in the absence of known
cancer susceptibility gene mutation.
II. Women who are approaching surgery for resection of a pelvic mass, which is considered
suspicious for neoplasia by radiologic or clinical criteria; such women may or may not
also meet criteria for inclusion in group I.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
James M Ford
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
BRSNSTU0020
NCT ID:
NCT01034033
Start Date:
August 2001
Completion Date:
December 2015
Related Keywords:
- Breast Cancer
- Ovarian Cancer
- Gynecologic Cancers
- Ovarian/Peritoneal/Fallopian Cancer
- quality of life
- Breast Neoplasms
- Ovarian Neoplasms
Name | Location |
|---|---|
| Stanford University School of Medicine | Stanford, California 94305-5317 |
